Literature DB >> 12750893

Simultaneous segmental obstruction of bile duct and portal vein markedly changes a population of biliary and hepatic cells in human liver.

Takanori Kyokane1, Masato Nagino, Junichi Kamiya, Yuji Nimura, Tetsuro Nagasaka.   

Abstract

BACKGROUND AND AIMS: No studies have investigated histologic changes caused by simultaneous segmental obstruction of the bile duct and portal vein in human liver. PATIENTS/
METHODS: Liver tissues with simultaneous obstruction of the segmental bile duct and portal vein (O(+/+) liver), with segmental bile duct obstruction alone (O(+/-) liver), and without obstruction (O(-/-) liver) were obtained from patients who underwent hepatectomy, and studied morphologically and immunohistochemically.
RESULTS: In O(+/+) liver, the proportional area consisting of hepatocytes was significantly less (31.0+/-25.8%) than in O(+/-) liver (78.4+/-18.9%) or O(-/-) liver (86.5+/-9.2%). In contrast, the proportional area consisting of biliary epithelial cells was significantly higher in O(+/+) liver (9.1+/-6.1%) than in O(+/-) liver (1.6+/-1.5%) or O(-/-) liver (0.7+/-0.6%). The proportional area consisting of fibrous tissue also was significantly higher in O(+/+) liver than in the other two groups. In O(+/+) liver, some cells located at the periphery of hepatocyte areas were immunoreactive for both hepatocyte and biliary epithelial cell markers.
CONCLUSION: Simultaneous segmental obstruction of the bile duct and portal vein induces a marked ductular increase, periportal fibrosis, and a reduction in the number of hepatocytes in human liver tissue.

Entities:  

Mesh:

Year:  2003        PMID: 12750893     DOI: 10.1007/s00423-003-0380-8

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  25 in total

1.  Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors.

Authors:  A E Wennerberg; M A Nalesnik; W B Coleman
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

2.  Preoperative portal vein embolization: an audit of 84 patients.

Authors:  H Imamura; R Shimada; M Kubota; Y Matsuyama; A Nakayama; S Miyagawa; M Makuuchi; S Kawasaki
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

3.  The cell cycle associated change of the Ki-67 reactive nuclear antigen expression.

Authors:  K Sasaki; T Murakami; M Kawasaki; M Takahashi
Journal:  J Cell Physiol       Date:  1987-12       Impact factor: 6.384

4.  Ligation of portal vein branch induces DNA polymerases alpha, delta, and epsilon in nonligated lobes.

Authors:  E Takeuchi; Y Nimura; S Mizuno; M Nagino; M Shoji-Kawaguchi; S Izuta; S Yoshida
Journal:  J Surg Res       Date:  1996-09       Impact factor: 2.192

Review 5.  Ductular reaction in the liver.

Authors:  V Desmet; T Roskams; P Van Eyken
Journal:  Pathol Res Pract       Date:  1995-07       Impact factor: 3.250

6.  Hepatocellular carcinoma with biliary tumor thrombi: aggressive operative approach after appropriate preoperative management.

Authors:  M Shiomi; J Kamiya; M Nagino; K Uesaka; T Sano; N Hayakawa; M Kanai; H Yamamoto; Y Nimura
Journal:  Surgery       Date:  2001-06       Impact factor: 3.982

7.  Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat.

Authors:  P A Slott; M H Liu; N Tavoloni
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

8.  Intrasplenic hepatocyte transplantation in rats with experimental liver injury: morphological and morphometric studies.

Authors:  K J Hillan; A D Burt; W D George; R N MacSween; M R Griffiths; J A Bradley
Journal:  J Pathol       Date:  1989-09       Impact factor: 7.996

9.  Origin and involution of hyperplastic bile ductules following total biliary obstruction.

Authors:  J A Gall; P S Bhathal
Journal:  Liver       Date:  1990-04

10.  Fate of the human liver after hemihepatic portal vein embolization: cell kinetic and morphometric study.

Authors:  H Harada; H Imamura; S Miyagawa; S Kawasaki
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.